-
Human Immunodeficiency Virus (HIV) (Event Driven)
Pharmacor, 2010
Last Updated 9 September 2010
The HIV market is highly dynamic, with one of the most
active pipelines, significant investment in R&D, and continually...
-
Psoriasis (Event Driven)
Pharmacor, 2010
Last Updated 3 September 2010
Despite the major impact psoriasis has on patients’ quality
of life, physicians believe many patients are untreated or...
-
Fibromyalgia (Event Driven)
Pharmacor, 2010
Last Updated 2 September 2010
Fibromyalgia affects an estimated 16 million people across
the major pharmaceutical markets and is one of the most...
-
Alzheimer's Disease (Event Driven)
Pharmacor, 2010
Last Updated 2 September 2010
Despite a large and rapidly growing patient population, the
treatment of Alzheimer’s disease (AD) consists only of...
-
Asthma (Event Driven)
Pharmacor, 2010
Last Updated 2 September 2010
With a large and growing patient population, the asthma
market is one of the most lucrative drug markets in the...
-
Parkinson's Disease (Event Driven)
Pharmacor, 2010
Last Updated 1 September 2010
Parkinson’s disease (PD) is one of the most common chronic
neurodegenerative diseases in the elderly. The PD therapy...
-
Colorectal Cancer (Event Driven)
Pharmacor, 2010
In 2009, colorectal cancer (CRC) was the third-most
diagnosed cancer in the United States. We expect the number of incident cases
of CRC to increase between...
-
Chronic Obstructive Pulmonary Disease (Event Driven)
Pharmacor, 2010
Last Updated 30 August 2010
The sizeable therapeutic market for chronic obstructive
pulmonary disease (COPD), a disease that is closely affiliated...
-
Osteoporosis (Event Driven)
Pharmacor, 2010
Last Updated 24 August 2010
Osteoporosis and osteopenia raise the risk of suffering a
fracture. Fractures are a substantial public health and...
-
Prostate Cancer (Event Driven)
Pharmacor, 2010
Last Updated 23 August 2010
Prostate cancer (CaP) was the leading cause of new cancer
cases and the second highest cause of cancer-related deaths...
-
Bipolar Disorder (Event Driven)
Pharmacor, 2010
Last Updated 23 August 2010
Bipolar disorder (BPD) is a chronic and debilitating
psychiatric illness. Found across all major pharmaceutical markets,...
-
Irritable Bowel Syndrome (Event Driven)
Pharmacor, 2010
Last Updated 23 August 2010
Although a highly prevalent condition, irritable bowel
syndrome (IBS) is marked by low diagnosis and treatment rates in...
-
Obesity (Event Driven)
Pharmacor, 2010
Last Updated 11 August 2010
In 2009, as the prevalence of obesity in
the pharmaceutical markets under studyapproached 35%, the
medical costs...
-
Unipolar Depression (formerly Major Depressive Disorder)
Pharmacor, 2010
Last Updated 10 August 2010
In the recent past,
depression presented drug developers with numerous lucrative market
opportunities because of its...
-
Multiple Sclerosis (Event Driven)
Pharmacor, 2010
Last Updated 10 August 2010
The multiple sclerosis (MS) market is poised to undergo a
dramatic transformation as eight new therapies enter the...
-
Schizophrenia (Event Driven)
Pharmacor, 2010
Last Updated 5 August 2010
The mature schizophrenia market will suffer a decline in
sales over our 2009-2019 forecast period as additional generic...
-
Venous Thromboembolism (Event Driven)
Pharmacor, 2010
Last Updated 5 August 2010
Venous thromboembolism (VTE) comprises both deep vein
thrombosis (DVT) and pulmonary embolism (PE) and represents a...
-
Systemic Lupus Erythematosus (Event Driven)
Pharmacor, 2010
Last Updated 4 August 2010
In the past, systemic lupus
erythematosus (SLE) drug developers faced formidable challenges: drug
development and...
-
Gastric Cancer (Event Driven)
Pharmacor, 2010
Last Updated 29 July 2010
Gastric cancer (GC) is the fourth-most common malignancy in
terms of incidence and is the second-most common cause of...
-
Multiple Myeloma (Event Driven)
Pharmacor, 2010
Last Updated 28 July 2010
In 2009, multiple myeloma was the second most commonly
diagnosed hematologic malignancy in the United States after...